Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Opinion & Analysis IMV Inc IMVIQ

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.

Opinion & Analysis (GREY:IMVIQ)

    Biopharma's Early Data Show Immunotherapy's Efficacy in Ovarian Cancer

    Streetwise Reports April 1, 2019

    Analyst: Biopharma Makes 'Right Call' in Stopping Combination Agent in Trial

    Streetwise Reports December 21, 2018

    Cancer Vaccine Developer Expands Its Collaboration with Merck

    Streetwise Reports September 20, 2018

    Study Shows Biopharma's Lead Drug Mediates T Cell Tumor Infiltration

    Streetwise Reports July 11, 2018

    Cancer in the Crosshairs: IMV Looks to Deliver Immunotherapy a New Way

    Streetwise Reports May 16, 2018